Skip to main content
Log in

Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

In this work, we analyzed the prognostic significance of changes in hemoglobin during intensive care unit (ICU) stay in patients with acute coronary syndromes (ACS). We prospectively enrolled 591 patients (62 ± 14 years old, 73% male, 48% ST elevated myocardial infarction) free of blood cell transfusion or bleeding events. Changes in hemoglobin between admission and ICU discharge were obtained. The primary endpoint was death or hospitalization for MI within 6 months. Hemoglobin decreased from 13.65 ± 1.77 to 13.17 ± 1.74 g/dl, p < 0.0001 in the whole population. The end point was reached in 43 patients at a mean follow-up of 180 (range 2–180 days). A decrease in hemoglobin ≥0.9 g/dl (32% of the population) was associated with adverse clinical outcomes (HR 2.37, 95% CI (1.30–4.35), p = 0.005, respectively). In multivariate analysis, age >77 year-old (p = 0.0016), Killip class ≥2 (p = 0.009), anemia (p = 0.0064), decreased estimated glomerular filtration rate (p = 0.003), and hemoglobin decline ≥0.9 g/dl (p < 0.0001) were independently associated with outcome. Hemoglobin decline and anemia both provided additional prognostic information on top of the GRACE score, as demonstrated by a systematic improvement in model global fit, discrimination, and calibration. Hemoglobin decline is frequent during ICU stay in non-bleeding ACS patients. A decline in hemoglobin ≥0.9 g/dl identifies high-risk patients. Identification of these patients refines the prognostic value of the GRACE score.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Catakoglu AB, Aytekin S, Sener M, Kurtoglu H, Celebi H, Demiroglu IC, Aytekin V (2007) Impact of anemia on nonfatal coronary events after percutaneous coronary interventions. Heart Vessels 22:383–388

    Article  PubMed  Google Scholar 

  2. Lee RJ, Shih KN, Lee SH, Shyu KG, Chiu CZ, Lin SC, Hung HF, Liou JY, Cheng JJ, Kuan P (2007) Predictors of long-term outcomes in patients after elective stent implantation for unprotected left main coronary artery disease. Heart Vessels 22:99–103

    Article  PubMed  Google Scholar 

  3. Turner SJ, Ketch TR, Gandhi SK, Sane DC (2008) Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes. Am Heart J 155:806–816

    Article  PubMed  Google Scholar 

  4. Meneveau N, Schiele F, Seronde MF, Descotes-Genon V, Oettinger J, Chopard R, Ecarnot F, Bassand JP (2009) Anemia for risk assessment of patients with acute coronary syndromes. Am J Cardiol 103:442–447

    Article  PubMed  Google Scholar 

  5. Lipsic E, van der Horst IC, Voors AA, van der Meer P, Nijsten MW, van Gilst WH, van Veldhuisen DJ, Zijlstra F (2005) Hemoglobin levels and 30-day mortality in patients after myocardial infarction. Int J Cardiol 100:289–292

    Article  PubMed  Google Scholar 

  6. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Cohen DA, Negoita M, Lansky AJ, Stone GW (2004) Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 44:547–553

    Article  PubMed  Google Scholar 

  7. Budaj A, Eikelboom JW, Mehta SR, Afzal R, Chrolavicius S, Bassand JP, Fox KA, Wallentin L, Peters RJ, Granger CB, Joyner CD, Yusuf S (2009) Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. Eur Heart J 30:655–661

    Article  PubMed  Google Scholar 

  8. Alexander KP, Chen AY, Wang TY, Rao SV, Newby LK, LaPointe NM, Ohman EM, Roe MT, Boden WE, Harrington RA, Peterson ED (2008) Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. Am Heart J 155:1047–1053

    Article  PubMed  Google Scholar 

  9. Aronson D, Suleiman M, Agmon Y, Suleiman A, Blich M, Kapeliovich M, Beyar R, Markiewicz W, Hammerman H (2007) Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J 28:1289–1296

    Article  PubMed  CAS  Google Scholar 

  10. Previsdomini M, Stocker R, Corti R, Cerutti B, Perren A (2007) Time course of hemoglobin concentrations in the intensive care unit in nonbleeding patients with acute coronary syndrome. Am J Cardiol 100:579–582

    Article  PubMed  CAS  Google Scholar 

  11. Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. J Am Coll Cardiol 50:2173–2195

    Article  PubMed  Google Scholar 

  12. Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. Eur Heart J 28:2525–2538

    Article  PubMed  Google Scholar 

  13. Langford K, Luchtman-Jones L, Miller R, Walck D (2003) Performance evaluation of the Sysmex XT-2000i automated hematology analyzer. Lab Hematol 9:29–37

    PubMed  CAS  Google Scholar 

  14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470

    PubMed  CAS  Google Scholar 

  15. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A, Goodman SG, Flather MD, Anderson FA Jr, Granger CB (2006) Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333:1091

    Article  PubMed  Google Scholar 

  16. Schoenfeld D (1982) Partial residuals for the proportional hazards regression model. Biometrika 69:239–241

    Article  Google Scholar 

  17. May S, Hosmer DW (2004) An added variable goodness-of-fit test for the Cox proportional hazards model. Biom J 46:343–350

    Article  Google Scholar 

  18. Harrell FE, Lee KL, Mark DB (1996) Multivariable prognostic models issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387

    Article  PubMed  Google Scholar 

  19. Kent JT, O’Quigley J (1988) Measures of dependence for censored survival data. Biometrika 75:525–534

    Article  Google Scholar 

  20. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E (2005) Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111:2042–2049

    Article  PubMed  CAS  Google Scholar 

  21. Kimura H, Hiramitsu S, Miyagishima K, Mori K, Yoda R, Kato S, Kato Y, Morimoto S, Hishida H, Ozaki Y (2010) Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure. Heart Vessels 25:306–312

    Article  PubMed  Google Scholar 

  22. Marechaux S, Six-Carpentier MM, Bouabdallaoui N, Montaigne D, Bauchart JJ, Mouquet F, Auffray JL, Le Tourneau T, Asseman P, Lejemtel TH, Ennezat PV (2010) Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction. Heart Vessels. doi:10.1007/s00380-010-0057-5

  23. Bassand JP, Afzal R, Eikelboom J, Wallentin L, Peters R, Budaj A, Fox KA, Joyner CD, Chrolavicius S, Granger CB, Mehta S, Yusuf S (2010) Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J 31:50–58

    Article  PubMed  CAS  Google Scholar 

  24. Dauerman HL, Lessard D, Yarzebski J, Gore JM, Goldberg RJ (2005) Bleeding complications in patients with anemia and acute myocardial infarction. Am J Cardiol 96:1379–1383

    Article  PubMed  Google Scholar 

  25. Sjauw KD, van der Horst IC, Nijsten MW, Nieuwland W, Zijlstra F (2006) Value of routine admission laboratory tests to predict thirty-day mortality in patients with acute myocardial infarction. Am J Cardiol 97:1435–1440

    Article  PubMed  Google Scholar 

  26. Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB (2004) Anemia and its relationship to clinical outcome in heart failure. Circulation 110:149–154

    Article  PubMed  Google Scholar 

  27. O’Riordan E, Foley RN (2000) Effects of anaemia on cardiovascular status. Nephrol Dial Transplant 15(Suppl 3):19–22

    PubMed  Google Scholar 

  28. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O (1999) Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34:125–134

    Article  PubMed  CAS  Google Scholar 

  29. Liron M (2007) Nosocomial anaemia. Eur Heart J 28:2551 (author reply 2551–2552)

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Eric Van Belle or Pierre Vladimir Ennezat.

Additional information

S. Maréchaux and S. Barrailler equally contributed to the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maréchaux, S., Barrailler, S., Pinçon, C. et al. Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. Heart Vessels 27, 119–127 (2012). https://doi.org/10.1007/s00380-011-0127-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-011-0127-3

Keywords

Navigation